155 related articles for article (PubMed ID: 34267018)
1. [From the Standpoint of a Core Center Hospital for Cancer Genome Medicine-Establishment of a Provision System for Wide-Area Precision Oncology].
Muto M; Kondo T; Yoshioka M; Fukuyama K; Suga J; Sato M; Masuda F; Ashida K; Mukai K; Matsumoto S; Kanai M
Gan To Kagaku Ryoho; 2021 Jul; 48(7):866-872. PubMed ID: 34267018
[TBL] [Abstract][Full Text] [Related]
2. [Current Status and Future Direction of Cancer Genomic Medicine in Japan].
Muto M
Gan To Kagaku Ryoho; 2020 Feb; 47(2):197-202. PubMed ID: 32381946
[TBL] [Abstract][Full Text] [Related]
3. [Precision Medicine Provided by National Health Insurance].
Muto M; Kondo T; Matsubara J; Kanai M; Matsumoto S; Ashida K; Suga J; Mukai K
Gan To Kagaku Ryoho; 2020 Aug; 47(8):1158-1163. PubMed ID: 32829347
[TBL] [Abstract][Full Text] [Related]
4. The initial assessment of expert panel performance in core hospitals for cancer genomic medicine in Japan.
Sunami K; Naito Y; Aimono E; Amano T; Ennishi D; Kage H; Kanai M; Komine K; Koyama T; Maeda T; Morita S; Sakai D; Kohsaka S; Tsuchihara K; Yoshino T
Int J Clin Oncol; 2021 Mar; 26(3):443-449. PubMed ID: 33385275
[TBL] [Abstract][Full Text] [Related]
5. [Panel Discussion - Problems in the Cancer Genomic Medicine].
Ishioka C; Muto M; Yachida S; Shirota H; Hirasawa A; Miyagawa K; Ashizawa K; Kinoshita I; Nishihara H; Matsuura N; Sakurai A
Gan To Kagaku Ryoho; 2022 Sep; 49(9):1014-1017. PubMed ID: 36156030
[TBL] [Abstract][Full Text] [Related]
6. [The Role of Core Hospitals and Cooperative Hospitals for Cancer Genomic Medicine in Japan].
Sunami K
Gan To Kagaku Ryoho; 2019 Apr; 46(4):617-621. PubMed ID: 31164495
[TBL] [Abstract][Full Text] [Related]
7. [Development of a System for Providing Cancer Genomic Medicine in Hokkaido-From the Standpoint of a Designated Core Hospital for Cancer Genomic Medicine].
Kinoshita I; Kikuchi J; Ohhara Y; Amano T; Akita H
Gan To Kagaku Ryoho; 2021 Jul; 48(7):882-886. PubMed ID: 34267021
[TBL] [Abstract][Full Text] [Related]
8. [Cooperative Tasks among Cancer Genome Medicine Facilities].
Shirota H
Gan To Kagaku Ryoho; 2022 Sep; 49(9):997-999. PubMed ID: 36156024
[TBL] [Abstract][Full Text] [Related]
9. [The Roles of Designated Core Hospitals and Cooperative Hospitals for Cancer Genomic Medicine in Japan].
Nishida T
Gan To Kagaku Ryoho; 2018 Sep; 45(9):1223-1227. PubMed ID: 30237359
[TBL] [Abstract][Full Text] [Related]
10. Establishment and implementation of Cancer Genomic Medicine in Japan.
Mukai Y; Ueno H
Cancer Sci; 2021 Mar; 112(3):970-977. PubMed ID: 33289217
[TBL] [Abstract][Full Text] [Related]
11. [Preparation of the Cancer Genomic Medicine in the Tohoku District-Activity of Tohoku University Hospital as the Cancer Genome Medicine Core Base Hospital in Japan].
Ishioka C
Gan To Kagaku Ryoho; 2021 Jul; 48(7):878-881. PubMed ID: 34267020
[TBL] [Abstract][Full Text] [Related]
12. Human resources for administrative work to carry out a comprehensive genomic profiling test in Japan.
Kage H; Oda K; Muto M; Tsuchihara K; Okita N; Okuma Y; Kikuchi J; Shirota H; Hayashi H; Kokuryo T; Sakai D; Hirasawa A; Kubo M; Kenmotsu H; Akiyama N; Shinozaki-Ushiku A; Tanabe M; Ushiku T; Miyagawa K; Seto Y
Cancer Sci; 2023 Jul; 114(7):3041-3049. PubMed ID: 37165760
[TBL] [Abstract][Full Text] [Related]
13. Chronological improvement in precision oncology implementation in Japan.
Sunami K; Naito Y; Komine K; Amano T; Ennishi D; Imai M; Kage H; Kanai M; Kenmotsu H; Koyama T; Maeda T; Morita S; Sakai D; Kohsaka S; Tsuchihara K; Saigusa Y; Yoshino T
Cancer Sci; 2022 Nov; 113(11):3995-4000. PubMed ID: 35976133
[TBL] [Abstract][Full Text] [Related]
14. [Data-Sharing Systems of the Center for Cancer Genomics and Advanced Therapeutics(C-CAT)Repository Database and Expectation for the Future Medical Research and Development].
Suzuki T
Gan To Kagaku Ryoho; 2022 Nov; 49(11):1175-1182. PubMed ID: 36412016
[TBL] [Abstract][Full Text] [Related]
15. [Interinstitutional Collaboration for Molecular Tumor Boards].
Komine K; Shirota H
Gan To Kagaku Ryoho; 2019 Apr; 46(4):626-629. PubMed ID: 31164497
[TBL] [Abstract][Full Text] [Related]
16. Current Clinical Practice of Precision Medicine Using Comprehensive Genomic Profiling Tests in Biliary Tract Cancer in Japan.
Kanai M
Curr Oncol; 2022 Sep; 29(10):7272-7284. PubMed ID: 36290850
[TBL] [Abstract][Full Text] [Related]
17. C-CAT: The National Datacenter for Cancer Genomic Medicine in Japan.
Kohno T; Kato M; Kohsaka S; Sudo T; Tamai I; Shiraishi Y; Okuma Y; Ogasawara D; Suzuki T; Yoshida T; Mano H
Cancer Discov; 2022 Nov; 12(11):2509-2515. PubMed ID: 36321305
[TBL] [Abstract][Full Text] [Related]
18. Cancer genomic medicine in Japan.
Mano H
Proc Jpn Acad Ser B Phys Biol Sci; 2020; 96(7):316-321. PubMed ID: 32788553
[TBL] [Abstract][Full Text] [Related]
19. Prospects and Problems of Cancer Genome Analysis for Establishing Cancer Precision Medicine.
Hayashi T; Konishi I
Cancer Invest; 2019; 37(9):427-431. PubMed ID: 31451055
[TBL] [Abstract][Full Text] [Related]
20. [Current Status and Prospects of the Comprehensive Cancer Genome Profiling].
Imoto I; Fukue M; Takaiso N
Gan To Kagaku Ryoho; 2021 Jan; 48(1):7-11. PubMed ID: 33468714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
